Abstract
Adults with hypopituitarism and documented growth hormone deficiency are now eligible for replacement therapy. What are the guidelines for diagnosis and treatment? More broadly, what are the implications for other adults with hyposomatotropism-namely, the elderly? And is there a therapeutic role for the hormone in patients with disease states such as osteoporosis, heart failure, and acute catabolic illness?
MeSH terms
-
Adult
-
Aging / drug effects
-
Aging / physiology
-
Cardiomyopathies / drug therapy
-
Female
-
Growth Disorders / drug therapy
-
Human Growth Hormone / adverse effects
-
Human Growth Hormone / deficiency
-
Human Growth Hormone / pharmacology
-
Human Growth Hormone / physiology
-
Human Growth Hormone / therapeutic use*
-
Humans
-
Insulin-Like Growth Factor I / deficiency
-
Insulin-Like Growth Factor I / physiology
-
Male
-
Osteoporosis / drug therapy
Substances
-
Human Growth Hormone
-
Insulin-Like Growth Factor I